Trial Profile
Abuse Liability Study of Staccato Alprazolam for Inhalation in Subjects With Histories of Sedative Abuse
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Alprazolam (Primary) ; Alprazolam (Primary)
- Indications Anxiety disorders; Panic disorder
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 12 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2009 Actual end date January 2009 added as reported by ClinicalTrials.gov.
- 08 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009 as reported by ClinicalTrials.gov.